Andrew Hammet

Title: The Innovations of Andrew Hammet

Introduction

Andrew Hammet is a notable inventor based in Parkville, Australia. He has made significant contributions to the field of biochemistry, particularly through his work on serum albumin variants. His innovative approach has led to advancements that may have important applications in medicine.

Latest Patents

Andrew Hammet holds a patent for "Human serum albumin variants and uses thereof." This patent describes a serum albumin variant, or functional fragment thereof, which includes specific amino acid substitutions. These substitutions are selected from glycine, isoleucine, lysine, methionine, phenylalanine, tryptophan, tyrosine, valine, and leucine substituted for glutamine at position 522; valine substituted for alanine at position 552; and alanine, glutamic acid, histidine, serine, lysine, and arginine substituted for glycine at position 572. He has 1 patent to his name.

Career Highlights

Andrew is associated with CSL Limited, a leading global biotechnology company. His work at CSL Limited has allowed him to focus on developing innovative solutions in the field of human health. His contributions have been instrumental in advancing the understanding and application of serum albumin variants.

Collaborations

Andrew collaborates with talented professionals in his field, including Sabine Rauth and Kirsten Edwards. These collaborations enhance the research and development efforts at CSL Limited, fostering an environment of innovation and discovery.

Conclusion

Andrew Hammet's work exemplifies the spirit of innovation in the biotechnology sector. His patent on human serum albumin variants showcases his commitment to advancing medical science. Through his career at CSL Limited and collaborations with esteemed colleagues, he continues to make a significant impact in his field.